Correlation Between Sidetrade and Sartorius Stedim

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sidetrade and Sartorius Stedim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sidetrade and Sartorius Stedim into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sidetrade and Sartorius Stedim Biotech, you can compare the effects of market volatilities on Sidetrade and Sartorius Stedim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sidetrade with a short position of Sartorius Stedim. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sidetrade and Sartorius Stedim.

Diversification Opportunities for Sidetrade and Sartorius Stedim

0.15
  Correlation Coefficient

Average diversification

The 3 months correlation between Sidetrade and Sartorius is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Sidetrade and Sartorius Stedim Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Stedim Biotech and Sidetrade is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sidetrade are associated (or correlated) with Sartorius Stedim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Stedim Biotech has no effect on the direction of Sidetrade i.e., Sidetrade and Sartorius Stedim go up and down completely randomly.

Pair Corralation between Sidetrade and Sartorius Stedim

Assuming the 90 days trading horizon Sidetrade is expected to generate 0.61 times more return on investment than Sartorius Stedim. However, Sidetrade is 1.64 times less risky than Sartorius Stedim. It trades about 0.08 of its potential returns per unit of risk. Sartorius Stedim Biotech is currently generating about -0.02 per unit of risk. If you would invest  22,000  in Sidetrade on August 31, 2024 and sell it today you would earn a total of  500.00  from holding Sidetrade or generate 2.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sidetrade  vs.  Sartorius Stedim Biotech

 Performance 
       Timeline  
Sidetrade 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Sidetrade are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Sidetrade may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Sartorius Stedim Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak primary indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Sidetrade and Sartorius Stedim Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sidetrade and Sartorius Stedim

The main advantage of trading using opposite Sidetrade and Sartorius Stedim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sidetrade position performs unexpectedly, Sartorius Stedim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Stedim will offset losses from the drop in Sartorius Stedim's long position.
The idea behind Sidetrade and Sartorius Stedim Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world